Lygature is an independent not-for-profit organization based in the Netherlands that catalyzes the development of new medical solutions for patients by driving public-private collaboration between academia, industry, and society. We focus on solutions that involve or combine medical technology and pharmacotherapy, and increase health, wealth, and social responsibility.
The creation of Lygature from the 2015 merger of CTMM and TI Pharma also recognizes the growing interdependence of medicines and medical technology. Researchers have gained important insights into the impact of genetics, environment, and lifestyle on health and disease, and society wants novel medical solutions tailored to individual patient characteristics. Creating these requires integration of diagnostics/imaging with pharmacology – and the respective expertise of CTMM and TI Pharma in these fields gives Lygature an ability to collaborate on the most complex projects.
With a goal of supporting collaboration and helping partners to deal with complexity, Lygature works across five main themes:
Our focus is on understanding partners’ needs and interests; supporting scientific credibility; assisting translation to patient benefits; and providing the services needed to manage consortia. In short, supporting all steps along the pathway from discovery to development to launch, and beyond to sustainability.